Literature DB >> 22555027

Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute.

Antonio A Ornellas1, Dennyson M Andrade, Paulo Ornellas, Aristóteles Wisnescky, Aline B de Santos Schwindt.   

Abstract

PURPOSE: We evaluated the role of several prognostic factors in predicting death and/or progressive disease in patients with renal cell carcinoma.
MATERIALS AND METHODS: Between 2004 and 2010, 227 consecutive patients with renal cell carcinoma underwent radical nephrectomy at our Institute. All histological specimens were examined by the same pathologist. We considered certain histological parameters, including histological subtype, conventional Fuhrman grade, presence of sarcomatoid features, adrenal gland infiltration, invasion of the perinephric fat, vascular embolization, collecting system invasion, presence or absence of tumour necrosis (0 %, 1 % to 49 %, or 50 % or greater) and regional lymph node metastasis.
RESULTS: Variables significantly associated with death and/or progressive disease on univariate analysis were histological subtype (p = 0.006), Fuhrman grade (p < 0.0001), tumor necrosis (p = 0.009), perinephric fat invasion (p = 0.002), vascular embolization (p = 0.0002), presence of lymph node involvement (p < 0.002), tumor size (p = 0.0006), TNM stage (p < 0.00001) and presence of metastasis (p < 0.00001). In the multivariable model histological subtype, tumor necrosis, lymph node involvement and presence of metastasis were independent risk factors for disease-free survival (p = 0.011, 0.042, 0.025 and p < 0.0001, respectively).
CONCLUSION: Histological subtype, tumor necrosis, lymph node involvement and presence of metastasis proved to be independent prognostic factors for disease-free survival. Therefore, the presence and rate of tumor necrosis should always be informed by the pathologist and lymphadenectomy should be performed in all patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555027     DOI: 10.1590/s1677-55382012000200006

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  4 in total

1.  Genetic alterations of HER genes in chromophobe renal cell carcinoma.

Authors:  Wen Hui Weng; Ying Tzu Chen; Kai Jie Yu; Ying Hsu Chang; Cheng Keng Chuang; See Tong Pang
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

Review 2.  Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.

Authors:  Hui-Ming Jiang; Jin-Huan Wei; Zhi-Ling Zhang; Yong Fang; Bang-Fen Zhou; Zhen-Hua Chen; Jun Lu; Bing Liao; Fang-Jian Zhou; Jun-Hang Luo; Wei Chen
Journal:  Int Urol Nephrol       Date:  2015-11-20       Impact factor: 2.370

Review 3.  Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Luyao Chen; Hongzhao Li; Liangyou Gu; Xin Ma; Xintao Li; Fan Zhang; Yu Gao; Yang Fan; Yu Zhang; Yongpeng Xie; Xu Zhang
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

4.  Comparative analysis of histopathological subtypes of renal cell carcinoma in the Middle East compared to other world regions.

Authors:  Mark Khauli; Nassib Abou Heidar; Jad A Degheili; Nizar Hakam; Mouhamad Al-Moussawy; Mohammed Shahait; Jose El-Asmar; Gerges Bustros; Ali Merhe; Rami Nasr; Muhammad Bulbul; Wassim Wazzan; Albert El-Hajj; Ali Shamseddine; Hala Kfoury; Deborah Mukherji; Raja Khauli
Journal:  Urol Ann       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.